Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunopharmacology. 1999 Dec;45(1-3):69-74.

The involvement of kallikrein-kinin system in diabetes type I (insulitis).

Author information

  • 1PROSIVAD-CONICET, Facultad de Farmacia y BioquĂ­mica, Universidad de Buenos Aires, Argentina.

Abstract

Islet inflammation or insulitis is followed by selective destruction of the insulin secreting B-cell. Animal models of insulin-dependent diabetes mellitus (IDDM) have been used to characterize more fully insulitis, and our results with C57/BL/Ks mdb with low doses of streptozotocin (STZ) confirmed the disease. B1 receptor antagonist [Leu8]des-Arg9-BK has shown a significant effect on diabetic glycemia and renal control parameters. Compared to insulin, the drug was effective to prevent the insulitis and the renal damage. On the other hand, B2 receptor antagonist (HOE 140) and ACE-I (captopril) were only able to control the urinary diabetic proteinuria.

PMID:
10614992
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk